112 related articles for article (PubMed ID: 6884639)
41. [Echocardiographic evaluation of the long-term treatment of arterial hypertension with metoprolol].
Ricciardelli B; Volpe M; Serino C; De Simone A; Morrone G; Trimarco B; Rengo F; Condorelli M
Boll Soc Ital Cardiol; 1980; 25(9):1109-14. PubMed ID: 7284202
[No Abstract] [Full Text] [Related]
42. [Antihypertensive effectiveness and tolerance of slow-release metoprolol in fixed combination with chlorthalidone. Multicenter study on 93 patients].
Beltrami M; Antiga F; Bola U; Caponi S; De Ranieri P; Galli G; Gasparotti G; Guidicelli N; Natali P; Panvini F
Clin Ter; 1987 Feb; 120(4):317-21. PubMed ID: 2953532
[No Abstract] [Full Text] [Related]
43. [Therapy of arterial hypertension with a delayed-action clonidine and chlorthalidone combination].
Scali G; Del Vita M; Bompani R
Clin Ter; 1985 Apr; 113(2):111-6. PubMed ID: 4017490
[No Abstract] [Full Text] [Related]
44. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
Lavenius B; Hansson L
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
[TBL] [Abstract][Full Text] [Related]
45. Comparative study of hydrochlorothiazide and a fixed combination of metoprolol and hydrochlorothiazide essential hypertension.
Dafgärd T; Forsén B; Lindahl T
Ann Clin Res; 1981; 13 Suppl 30():37-44. PubMed ID: 7027892
[TBL] [Abstract][Full Text] [Related]
46. Once-a-day therapy in patients with moderate-to-severe hypertension.
McChesney JA
J Natl Med Assoc; 1984 Jul; 76 Suppl(Suppl):47-53. PubMed ID: 6471122
[No Abstract] [Full Text] [Related]
47. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
[TBL] [Abstract][Full Text] [Related]
48. [Evaluation of a combination of a diuretic and nifedipine retard for the treatment of hypertensive patients refractory to nifedipine retard].
Martínez López JJ; Rúiz López FJ; Gómez Márquez M; Ortega González G; Molina Boix M; Florenciano Sánchez R
An Med Interna; 1993 Aug; 10(8):386-9. PubMed ID: 8218783
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
Brandão AP; Oigman W; Albanesi Filho FM
Arq Bras Cardiol; 1981 Dec; 37(6):495-8. PubMed ID: 7347202
[No Abstract] [Full Text] [Related]
50. [Long-term study of the effects of chlorthalidone and amiloride on the renal excretion of electrolytes in patients with vascular hypertension].
Schück O; Nádvorníková H
Vnitr Lek; 1986 Jan; 32(1):54-61. PubMed ID: 3952996
[No Abstract] [Full Text] [Related]
51. Total body potassium in patients receiving chlorthalidone and metoprolol for hypertension.
Gray JM; Lawson DH; Boddy K; East W
Scott Med J; 1983 Apr; 28(2):172-5. PubMed ID: 6867699
[TBL] [Abstract][Full Text] [Related]
52. Once daily combination therapy for hypertension.
Asbury MJ; Wells FO; Barker NP
Practitioner; 1980 Dec; 224(1350):1306-9. PubMed ID: 7012818
[No Abstract] [Full Text] [Related]
53. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
Asplund J; Ohman P
Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
[TBL] [Abstract][Full Text] [Related]
54. [Alpha-blockers in therapy of arterial hypertension. No longer the drug of first choice].
Faulhaber HD
MMW Fortschr Med; 2001 May; 143(22):30-2. PubMed ID: 11460395
[No Abstract] [Full Text] [Related]
55. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
Channick BJ; Kessler WB; Marks AD; Adlin EV
Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
[TBL] [Abstract][Full Text] [Related]
56. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
[No Abstract] [Full Text] [Related]
57. [Verapamil as a hypotensive agent. Clinical, laboratory, electro- and echocardiographic study].
Talberg J; Fernandes EO; Chequer CV; Latreca CE; Reis NB
Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():36-40. PubMed ID: 7325861
[No Abstract] [Full Text] [Related]
58. [Effects of metoprolol and a combination of metoprolol and hydrochlorothiazide on arterial tension values in hypertensive patients at rest and following exertion. Crossed double-blind study].
Novo S; Davì G; Avellone G; Fazio M; Micci S; Modica R; Buzzetti G
Boll Soc Ital Cardiol; 1981; 26(2):117-29. PubMed ID: 7337767
[No Abstract] [Full Text] [Related]
59. Metoprolol and atropine in acute myocardial infarction.
Boyle DM; Barber JM; Evans A; McIlmoyle EL; Salathia KS; Shanks RG
Ir Med J; 1980 Dec; 73(12):477-8. PubMed ID: 7461938
[No Abstract] [Full Text] [Related]
60. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
